Pharmacological basis for antimicrobial therapy in newborn infants.
D000617:Aminoglycosides / Q000627:therapeutic use; D000667:Ampicillin / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000134:cerebrospinal fluid / Q000378:metabolism / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000097:blood / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D002228:Carbenicillin / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy* / Q000378:metabolism; D007700:Kinetics; D008431:Maternal-Fetal Exchange; D010406:Penicillins / Q000031:analogs & derivatives / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology / Q000627:therapeutic use; D011247:Pregnancy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D010406:Penicillins; D000667:Ampicillin; D002228:Carbenicillin